Skip to main content

Brief report: Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics

This is a preview of subscription content, access via your institution.

References

  • American Psychiatric Association. (1987).Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.

    Google Scholar 

  • Chapel, H., & Haeney, M. (Eds.). (1993).Essentials of clinical immunology (pp. 57–58). London: Blackwell.

    Google Scholar 

  • Donaghy, M., Mills, K. R., Boniface, S. J., Simmons, J., Wright, I., Gregson, N., & Jacobs, J. (1994). Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin.Journal of Neurology, Neurosurgery and Psychiatry, 57: 778–783.

    Google Scholar 

  • Dwyer, J. M. (1992). Manipulating the immune system with immune globulin.New England Journal of Medicine, 326, 4104–4109.

    Google Scholar 

  • Erkeller-Yuksel, F. M., Deneys, V., Yuksel, B., Hannet, I., Hulstaert, F., Hamilton, C., Mackinnon, H., Stokes, L. T., Munhyeshuli, V., Vanlangendonck, F., De Bruyere, M., Bach, B. A., & Lydyard, P. M. (1992). Age-related changes in human blood lymphocyte subpopulations.Journal of Pediatrics, 120, 216–222.

    Google Scholar 

  • Gillberg, C., & Coleman, M. (Eds.). (1992).The biology of the autistic syndromes (2nd ed., pp. 218–225). London: Mac Keith Press.

    Google Scholar 

  • Gupta, S. (1986). Current and potential future uses of intravenous gamma globulin in the treatment of autoimmune disorders.Immunology & Allergy Practice, 8, 370–377.

    Google Scholar 

  • Herberman, R. B., & Ortaldo, J. R. (1981). Natural killer cells: Their role in defense against disease.Science, 214, 24–30.

    Google Scholar 

  • Kanner, L. (1943). Autistic disturbances of affective contact.Nervous Child, 2, 2217–250.

    Google Scholar 

  • Koski, C. L. (1987). Complement fixing anti-peripheral myelin antibodies and C9 neoantigens in serum of patients with Guillain-Barre syndrome: Quantitation, kinetics and clinical correlation.Annals New York Academy of Science, 505, 319–325.

    Google Scholar 

  • Menage, P., Thibault, G., Barthelemy, C., Lelord, G., & Bardos, P. (1992). CD4+CD45RA+ T lymphocyte deficiency in autistic children: Effect of a pyridoxine-magnesium treatment.Brain Dysfunction, 5, 326–333.

    Google Scholar 

  • Mobini, N., Sarela, A., & Ahmed, A. R. (1995). Intravenous immunoglobulins in the therapy of autoimmune and systemic inflammatory disorders.Annals of Allergy, Asthma & Immunology, 74, 119–132.

    Google Scholar 

  • Romagnani, S. (1995). Biology of TH1 and TH2 cells.Journal of Clinical Immunology, 15, 121–129.

    Google Scholar 

  • Schwartz, S. A. (1990). Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders.Journal of Clinical Immunology, 10, 81–89.

    Google Scholar 

  • Singh, V. K., Warren, R. P., Odell, J. D., Warren, W. L., & Cole, P. (1993). Antibodies to myelin basic protein in children with autistic behavior.Brain, Behavior & Immunity, 7, 97–103.

    Google Scholar 

  • Stubbs, E. G. (1976). Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination.Journal of Autism and Childhood Schizophrenia, 6, 169–214.

    Google Scholar 

  • Stubbs, E. G., Crawford, M. L., Burger, D. R., & Vandebork, A. A. (1977). Depressed lymphocyte responsiveness in autistic children.Journal of Autism and Childhood Schizophrenia, 7, 49–55.

    Google Scholar 

  • Van der Meche, F. G. A., & Schmitz, P. I. M. (1992). A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barre syndrome.New England Journal of Medicine, 326, 1123–1129.

    Google Scholar 

  • Warren, R. P., Foster, A., & Margaretten, N. C. (1987). Reduced natural killer cell activity in autism.Journal of the American Academy of Child and Adolescent Psychiatry, 26, 333–335.

    Google Scholar 

  • Warren, R. P., Foster, A., Margaretten, N. C., & Pace, N. C. (1986). Immune abnormalities in patients with autism.Journal of Autism and Developmental Disorders, 16, 189–197.

    Google Scholar 

  • Warren, R. P., Yonk, L. I., Burger, R. A., Cole, P., Odell, J. D., Warren, W. L., White, E., & Singh, V. K. (1990). Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism.Immunological Investigation, 19, 245–251.

    Google Scholar 

  • Warren, R. P., Singh, V. K., Cole, P., Odell, J. D., Pingree, C. B., Warren, W. L., & White, E. (1991). Increased frequency of the null allele at the complement C4b locus in autism.Clinical and Experimental Immunology, 83, 438–440.

    Google Scholar 

  • Weizman, A., Weizman, R., Szekely, G. A., Wijsenbeek, H., & Livni, E. (1982). Abnormal immune response to brain tissue antigen in the syndrome of autism.American Journal of Psychiatry, 139, 1462–1465.

    Google Scholar 

  • Yman, L. (1991). Standardization of IgE antibody assays.Journal of International Federation of Clinical Chemistry, 3, 198–203.

    Google Scholar 

  • Yonk, L. J., Warren, R. P., Burger, R. A., Cole, P., Odell, J. D., Warren, W. L., White, E., & Singh, V. K. (1990). CD4+ helper T cell depression in autism.Immunology Letters, 25, 314–346.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

We thank Dr. Bernard Rimland, Autism Research Institute, San Diego, for his constructive comments and suggestions. This manuscript was approved by the Institutional Review Board.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gupta, S., Aggarwal, S. & Heads, C. Brief report: Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics. J Autism Dev Disord 26, 439–452 (1996). https://doi.org/10.1007/BF02172828

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02172828

Keywords

  • Immune System
  • Beneficial Effect
  • School Psychology
  • Immune Globulin
  • Autistic Characteristic